COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,884 Articles (22,568 medRxiv, 8,316 bioRxiv)

Most recent first Previous |  Page 1081: Articles 10801-10810  | Next

Acute SARS-CoV-2 infection in pregnancy is associated with placental ACE-2 shedding
Taglauer, E. S., Wachman, E. M., Juttukonda, L., Klouda, T., Kim, J., Wang, Q., Ishiyama, A., Hackam, D. J., Yuan, K., Jia, H.
10.1101/2021.11.19.469335 — Posted: 2021-11-22
Immune escape facilitation by mutations of epitope residues in RdRp of SARS-CoV-2
Mallick Gupta, A., Mandal, S. C., Chakrabarti, J., Mandal, S.
10.1101/2021.11.18.469065 — Posted: 2021-11-22
Characterization of SARS-CoV-2 public CD4+ αβ T cell clonotypes through reverse epitope discovery
Rosati, E., Pogorelyy, M. V., Minervina, A. A., Franke, A., Scheffold, A., Bacher, P., Thomas, P.
10.1101/2021.11.19.469229 — Posted: 2021-11-22
Self-assembling short immunostimulatory duplex RNAs with broad spectrum antiviral activity
Si, L., Bai, H., Oh, C. Y., Zhang, T., Jiang, A., Hong, F., Ye, Y., Jordan, T. X., Logue, J., McGrath, M., Belgur, C., Nurani, A., Cao, W., Powers, R. K., Prantil-Baun, R., Gygi, S. P., Frieman, M., tenOever, B. R., Ingber, D. E.
10.1101/2021.11.19.469183 — Posted: 2021-11-22
SARS-CoV-2 papain-like protease PLpro in complex with natural compounds reveal allosteric sites for antiviral drug design
Srinivasan, V., Brognaro, H., Prabhu, P. R., de Souza, E. E., Guenther, S., Reinke, P. Y. A., J. Lane, T., Ginn, H., Han, H., Ewert, W., Sprenger, J., Koua, F. H. M., Falke, S., Werner, N., Andaleeb, H., Ullah, N., Alves Franca, B., Wang, M., Luana C Barra, A., Perbandt, M., Schwinzer, M., Schmidt, C., Brings, L., Lorenzen, K., Schubert, R., Rahal Guaragna Machado, R., Donizette Candido, E., Bruna Leal Oliveira, D., Luiz Durigon, E., Yefanov, O., Lieske, J., Gelisio, L., Domaracky, M., Middendorf, P., Groessler, M., Trost, F., Galchenkova, M., Saouane, S., Hakanpaeae, J., Wolf, M., Turk, D., Pearson, A. R., Chapman, H. N., Hinrichs, W., Wrenger, C., Meents, A., Betzel, C.
10.1101/2021.11.17.468943 — Posted: 2021-11-22
ACE2 expression and localization are regulated by CFTR: implications beyond cystic fibrosis
Bezzerri, V., Gentili, V., Api, M., Finotti, A., Papi, C., Tamanini, A., Olioso, D., Duca, M., Tedesco, E., Leo, S., Borgatti, M., Volpi, S., Pinton, P., Cabrini, G., Gambari, R., Blasi, F., Lippi, G., Rimessi, A., Rizzo, R., cipolli, m.
10.1101/2021.11.19.469220 — Posted: 2021-11-22
Clinical Outcome of Neurological patients with COVID-19: the impact of Healthcare organization improvement between waves.
Cristillo, V., Pilotto, A., Benussi, A., Libri, I., Giunta, M., Morotti, A., Gipponi, S., Locatelli, M., Cotti Piccinelli, S., Mazzoleni, V., Schiano di Cola, F., Masciocchi, S., Pezzini, D., Scalvini, A., Premi, E., Cottini, E., Gamba, M., Magoni, M., Fontanella, M. M., Padovani, A.
10.1101/2021.11.19.21266606 — Posted: 2021-11-22
The Effect of COVID-19 on the Postdoctoral Experience: a comparison of pre-pandemic and pandemic surveys.
Morin, A., Helling, B. A., Krishnan, S., Risner, L. E., Walker, N. D., Schwartz, N. B.
10.1101/2021.11.19.468693 — Posted: 2021-11-21 Discussion: Offsite
ROLE OF BODY MASS AND PHYSICAL ACTIVITY IN AUTONOMIC FUNCTION MODULATION ON POST-COVID-19 CONDITION: AN OBSERVATIONAL SUBANALYSIS OF FIT-COVID STUDY
Freire, A. P. F., Santos de Lira, F., von Ah Morano, A. E., Pereira, T., Coelho Silva, M.-J., Caseiro, A., Destro Christofaro, D. G., Marchioto, O., Pires Dorneles, G., Aurino Pinho, R., Spolador de Alencar Silva, B.
10.1101/2021.11.17.21266473 — Posted: 2021-11-21
Antibody titers before and after booster doses of SARS-CoV-2 mRNA vaccines in healthy adults
Demonbreun, A. R., Sancillo, A., Vaught, L. A., Reiser, N. L., Pesce, L., McNally, E. M., McDade, T. W.
10.1101/2021.11.19.21266555 — Posted: 2021-11-21 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).